You Spoke, We Listened: The Completely At-Home RECONNECT Clinical Trial

Anna De Sonia
Anna De Sonia

02 mins read

Please Note: The team at Harmony Biosciences is excited to share that they have reached their enrollment goal for the Phase 3 RECONNECT trial, and screening has officially closed.

Participate in Research Without the Stress of Traveling

You can work from home, you can order groceries from home, and now you can participate in a clinical trial from home!

Dr. Carrie Buchanan headshot

“This is a trial that’s taking place at multiple centers across the United States, but there’s also a unique option for families that find traveling difficult or find it easier to stay home. There is a completely at-home option that allows your family to enroll and participate in the trial entirely from the comfort of your own home.” – Dr. Carrie Buchanan

At Harmony, we have heard from you how difficult it can be to get out of the house as a family with Fragile X syndrome. We listened, and that is why we now have the completely at home option for the RECONNECT clinical trial. Skip the travel and take advantage of the differences our At-Home option offers by participating from the comfort of your home.

About the Author

Anna De Sonia

Anna joined the NFXF team in 2024. She has many years of research experience, starting out as a clinical research coordinator at Rush University Medical Center in Chicago, IL back in 2010. There she worked on a variety of clinical trials in the pediatric neurology division, specializing in Fragile X research.